Zhongzhu Healthcare HoldingLtd Yönetim

Yönetim kriter kontrolleri 1/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Bo Anna Wang

İcra Kurulu Başkanı

CN¥1.2m

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	no data
CEO sahipliği	n/a
Yönetim ortalama görev süresi	Veri yok
Yönetim Kurulu ortalama görev süresi	5.6yrs

Son yönetim güncellemeleri

Recent updates

Zhongzhu Healthcare Holding Co.,Ltd's (SHSE:600568) Business Is Yet to Catch Up With Its Share Price

Sep 30

Zhongzhu Healthcare Holding Co.,Ltd (SHSE:600568) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected

May 13

CEO

Bo Anna Wang (61 yo)

no data

Görev süresi

CN¥1,200,000

Tazminat

Ms. Bo Anna Wang serves as President of Zhongzhu Healthcare Holding Co.,Ltd.

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Bao Long Qiao	VP & Director	5.6yrs	CN¥530.00k	Veri yok
Jige Ye	Chairman	5.6yrs	CN¥1.43m	0.17% CN¥ 4.7m
Dong Mei Huang	Member of the Supervisory Board	no data	Veri yok	Veri yok
Jian Li	Member of the Supervisory Board	no data	Veri yok	Veri yok
Yi Bin Zeng	Independent Director	5.6yrs	CN¥96.00k	Veri yok
Qin Xu	Employee Supervisor	4.2yrs	Veri yok	Veri yok
Lang Chen	Independent Director	no data	CN¥96.00k	Veri yok

5.6yrs

Ortalama Görev Süresi

49yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 600568 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 5.6 yıldır).

Zhongzhu Healthcare HoldingLtd Yönetim

Yönetim kriter kontrolleri 1/4

Anahtar bilgiler

Son yönetim güncellemeleri

Zhongzhu Healthcare Holding Co.,Ltd, Annual General Meeting, May 08, 2024

Insufficient new directors

Recent updates

Third quarter 2024 earnings released: CN¥0.014 loss per share (vs CN¥0.008 loss in 3Q 2023)

Zhongzhu Healthcare Holding Co.,Ltd's (SHSE:600568) Business Is Yet to Catch Up With Its Share Price

Zhongzhu Healthcare Holding Co.,Ltd to Report Q3, 2024 Results on Oct 31, 2024

New major risk - Financial data availability

Zhongzhu Healthcare Holding Co.,Ltd to Report First Half, 2024 Results on Aug 27, 2024

Zhongzhu Healthcare Holding Co.,Ltd (SHSE:600568) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected

First quarter 2024 earnings released: CN¥0.011 loss per share (vs CN¥0.014 loss in 1Q 2023)

Full year 2023 earnings released: CN¥0.17 loss per share (vs CN¥0.40 loss in FY 2022)

Zhongzhu Healthcare Holding Co.,Ltd, Annual General Meeting, May 08, 2024

Zhongzhu Healthcare Holding Co.,Ltd to Report Q1, 2024 Results on Apr 30, 2024

Zhongzhu Healthcare Holding Co.,Ltd to Report Fiscal Year 2023 Results on Apr 17, 2024

Third quarter 2023 earnings released: CN¥0.008 loss per share (vs CN¥0.009 loss in 3Q 2022)

Insufficient new directors

Second quarter 2023 earnings released: CN¥0.11 loss per share (vs CN¥0.011 loss in 2Q 2022)

Full year 2022 earnings released: CN¥0.40 loss per share (vs CN¥0.11 loss in FY 2021)

Third quarter 2022 earnings released: CN¥0.009 loss per share (vs CN¥0.008 loss in 3Q 2021)

Second quarter 2022 earnings released: CN¥0.011 loss per share (vs CN¥0.012 loss in 2Q 2021)

First quarter 2022 earnings released: CN¥0.002 loss per share (vs CN¥0.012 loss in 1Q 2021)

Full year 2021 earnings released: CN¥0.11 loss per share (vs CN¥0.002 profit in FY 2020)

Third quarter 2021 earnings released: CN¥0.008 loss per share (vs CN¥0.005 loss in 3Q 2020)

Second quarter 2021 earnings released: CN¥0.012 loss per share (vs CN¥0.003 loss in 2Q 2020)

Jilin Zhongke Bio-engineering Joint Stock Co., Ltd. signed the share transfer agreement to acquire a 51% stake in Zhongzhu Zhongke Stem Cell Gene Technology Co., Ltd. from Zhongzhu Healthcare Holding Co.,Ltd (SHSE:600568) for CNY 3 million.

Zeng Yamei won the bid and acquired 2.9% stake in Zhongzhu Healthcare Holding Co.,Ltd (SHSE:600568) from Zhuhai Zhongzhu Group Co., Ltd. for CNY 104.2 million.

Full year 2020 earnings released: EPS CN¥0.002 (vs CN¥0.18 loss in FY 2019)

Zhongzhu Healthcare's Shareholders to Sell 5.14% Stakes in the Company

New 90-day low: CN¥1.53

An unknown technology firm acquired 6.4% stake in Zhongzhu Healthcare Holding Co.,Ltd (SHSE:600568).

Xiao Feiying completed the acquisition of 6.26% stake in Zhongzhu Healthcare Holding Co.,Ltd (SHSE:600568) from the group of sellers.

Third quarter earnings released

Zhuhai Zhongzhu Co Ltd. agreed to be acquire the remaining 70.03% stake in Hubei Qianjiang Pharmaceutical Co., Ltd. (SHSE: 600568) in a reverse merger transaction .

First half earnings released

New 90-day high - CN¥1.50

Zhongzhu Healthcare Holding Co.,Ltd to Report First Half, 2020 Results on Aug 29, 2020

CEO

Görev süresi

Tazminat

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi

Ortalama Yaş